Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP350207.RAYXfOJRZ0xd7Xu9iJlhkVej4qGFyAYBkgEzGS4cEwEV0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP350207.RAYXfOJRZ0xd7Xu9iJlhkVej4qGFyAYBkgEzGS4cEwEV0130_assertion type Assertion NP350207.RAYXfOJRZ0xd7Xu9iJlhkVej4qGFyAYBkgEzGS4cEwEV0130_head.
- NP350207.RAYXfOJRZ0xd7Xu9iJlhkVej4qGFyAYBkgEzGS4cEwEV0130_assertion description "[Pharmacological modulation of the renal endogenous reparative process (that is, with angiotensin-converting enzyme inhibitors and AT1 angiotensin II receptor blockers), as well as future therapeutic strategies targeted to the renopoietic system, offers interesting perspectives for the management of hypertensive nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350207.RAYXfOJRZ0xd7Xu9iJlhkVej4qGFyAYBkgEzGS4cEwEV0130_provenance.
- NP350207.RAYXfOJRZ0xd7Xu9iJlhkVej4qGFyAYBkgEzGS4cEwEV0130_assertion evidence source_evidence_literature NP350207.RAYXfOJRZ0xd7Xu9iJlhkVej4qGFyAYBkgEzGS4cEwEV0130_provenance.
- NP350207.RAYXfOJRZ0xd7Xu9iJlhkVej4qGFyAYBkgEzGS4cEwEV0130_assertion SIO_000772 23803592 NP350207.RAYXfOJRZ0xd7Xu9iJlhkVej4qGFyAYBkgEzGS4cEwEV0130_provenance.
- NP350207.RAYXfOJRZ0xd7Xu9iJlhkVej4qGFyAYBkgEzGS4cEwEV0130_assertion wasDerivedFrom befree-20150227 NP350207.RAYXfOJRZ0xd7Xu9iJlhkVej4qGFyAYBkgEzGS4cEwEV0130_provenance.
- NP350207.RAYXfOJRZ0xd7Xu9iJlhkVej4qGFyAYBkgEzGS4cEwEV0130_assertion wasGeneratedBy ECO_0000203 NP350207.RAYXfOJRZ0xd7Xu9iJlhkVej4qGFyAYBkgEzGS4cEwEV0130_provenance.